TSXV - Delayed Quote CAD
LSL Pharma Group Inc. (LSL.V)
0.3500
+0.0050
+(1.45%)
At close: April 25 at 2:55:53 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
9/30/2020
Operating Cash Flow
-2,091
-7,070
-3,164
-1,084.9550
-117.8490
Investing Cash Flow
-5,752
-1,017
-997
-1,039.6920
-1,193.8380
Financing Cash Flow
8,037
8,095
3,420
940.1670
1,740.9500
End Cash Position
164
8
--
741.0100
462.1250
Capital Expenditure
-3,617
-1,017
-997
-914.7870
-85.5040
Issuance of Capital Stock
8,230
9,463
2,367
2,645
3,225
Issuance of Debt
4,997
4,768
3,960
5,319.6600
40
Repayment of Debt
-1,716
-2,785
-1,136
-4,770.3770
-289.2150
Free Cash Flow
-5,708
-8,087
-4,161
-1,999.7420
-203.3530
9/30/2020 - 3/2/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade